HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Outpatient polyclinic observations on senzit in the treatment of ischemic heart disease].

Abstract
56 patients, aged from 28 up to 60 years, with ischemic heart disease II-III functional class according to the Canadian classification were treated with the original Hungarian drug Sensit in out-patient conditions. The number of patients with anginal pain fell from 56 to 12 and the overall effect of the Sensit treatment was 84% (47 patients improved). The physical load tolerance significantly increased--from 58.2 to 67.4 W. Sensit influences the pathological ECG changes--ST segment lowering after physical load. It must be emphasized that the effect of the Sensit treatment is seen after a 3 week course of treatment at least. The drug is suitable for an out-patient treatment.
AuthorsA Kokutsov
JournalVutreshni bolesti (Vutr Boles) Vol. 29 Issue 1 Pg. 35-8 ( 1990) ISSN: 0506-2772 [Print] Bulgaria
Vernacular TitleAmbulatorno-poliklinichni nabliudeniia vŭrkhu senzit pri lechenie na iskhemichna bolest na sŭrtseto.
PMID2396416 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Phenethylamines
  • Fendiline
Topics
  • Adult
  • Ambulatory Care
  • Angina Pectoris (drug therapy, physiopathology)
  • Coronary Disease (drug therapy, physiopathology)
  • Drug Evaluation
  • Electrocardiography
  • Exercise Test
  • Female
  • Fendiline (therapeutic use)
  • Humans
  • Male
  • Middle Aged
  • Phenethylamines (therapeutic use)
  • Physical Endurance (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: